Literature DB >> 28433415

Effects of Transferring to the Rehabilitation Ward on Long-Term Mortality Rate of First-Time Stroke Survivors: A Population-Based Study.

Chien-Min Chen1, Yao-Hsu Yang2, Chia-Hao Chang3, Pau-Chung Chen4.   

Abstract

OBJECTIVE: To assess the long-term health outcomes of acute stroke survivors transferred to the rehabilitation ward.
DESIGN: Long-term mortality rates of first-time stroke survivors during hospitalization were compared among the following sets of patients: patients transferred to the rehabilitation ward, patients receiving rehabilitation without being transferred to the rehabilitation ward, and patients receiving no rehabilitation.
SETTING: Retrospective cohort study. PARTICIPANTS: Patients (N = 11,419) with stroke from 2005 to 2008 were initially assessed for eligibility. After propensity score matching, 390 first-time stroke survivors were included.
INTERVENTIONS: None. MAIN OUTCOME MEASURE: Cox proportional hazards regression model was used to assess differences in 5-year poststroke mortality rates.
RESULTS: Based on adjusted hazard ratios (HRs), the patients receiving rehabilitation without being transferred to the rehabilitation ward (adjusted HR, 2.20; 95% confidence interval [CI], 1.36-3.57) and patients receiving no rehabilitation (adjusted HR, 4.00; 95% CI, 2.55-6.27) had significantly higher mortality risk than the patients transferred to the rehabilitation ward. Mortality rate of the stroke survivors was affected by age ≥65 years (compared with age <45y; adjusted HR, 3.62), being a man (adjusted HR, 1.49), having ischemic stroke (adjusted HR, 1.55), stroke severity (Stroke Severity Index [SSI] score≥20, compared with SSI score<10; adjusted HR, 2.68), and comorbidity (Charlson-Deyo Comorbidity Index [CCI] score≥3, compared with CCI score=0; adjusted HR, 4.23).
CONCLUSIONS: First-time stroke survivors transferred to the rehabilitation ward had a 5-year mortality rate 2.2 times lower than those who received rehabilitation without transfer to the rehabilitation ward and 4 times lower than those who received no rehabilitation.
Copyright © 2016 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mortality; Rehabilitation; Stroke

Mesh:

Year:  2017        PMID: 28433415     DOI: 10.1016/j.apmr.2017.03.020

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  Constraint-induced movement therapy in treatment of acute and sub-acute stroke: a meta-analysis of 16 randomized controlled trials.

Authors:  Xi-Hua Liu; Juan Huai; Jie Gao; Yang Zhang; Shou-Wei Yue
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

Review 2.  Registry-based stroke research in Taiwan: past and future.

Authors:  Cheng-Yang Hsieh; Darren Philbert Wu; Sheng-Feng Sung
Journal:  Epidemiol Health       Date:  2018-02-04

3.  Use of non-contact infrared thermometers in rehabilitation patients: a randomized controlled study.

Authors:  Zhen Chen; Hui Wang; Yi Wang; Hongmei Lin; Xiuping Zhu; Yaqin Wang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

4.  Predictors for the use of traditional Chinese medicine among inpatients with first-time stroke: a population-based study.

Authors:  Wei-Sen Chen; Hung-Chih Hsu; Yi-Wen Chuang; Meng Lee; Kuan-Yu Lu; Yi-Fei Chen; Chien-Min Chen
Journal:  BMC Complement Med Ther       Date:  2020-08-06

5.  Machine learning to predict mortality after rehabilitation among patients with severe stroke.

Authors:  Domenico Scrutinio; Carlo Ricciardi; Leandro Donisi; Ernesto Losavio; Petronilla Battista; Pietro Guida; Mario Cesarelli; Gaetano Pagano; Giovanni D'Addio
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379

6.  Rehabilitation nursing for motor functional recovery of acute ischaemic stroke: study protocol for a randomised controlled trial.

Authors:  Jianmiao Wang; Yuanyuan Chen; Yuping Zhang; Mei Li; Jingfen Jin
Journal:  BMJ Open       Date:  2020-09-25       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.